MoneyWorks4Me

Lupin informs about board meeting

22 Apr 2024 Evaluate

Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Lupin has informed that a meeting of the Board of Directors of the Company will be held on Monday, May 6, 2024, to consider and take on record audited financial results of the Company for the quarter and year-ended March 31, 2024 and recommend dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..